Need to listen again. After all data was presented to FDA and discussing of Phase 3. Then they would know what CR figures would be required. Correct me if I'm wrong.
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1503 Acne Phase 2 Study Results Presentation
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-651
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
36.0¢ |
Change
-0.015(4.00%) |
Mkt cap ! $660.6M |
Open | High | Low | Value | Volume |
37.5¢ | 38.0¢ | 36.0¢ | $1.726M | 4.744M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 223236 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 370358 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 223236 | 0.360 |
17 | 796493 | 0.355 |
33 | 1260629 | 0.350 |
14 | 1815544 | 0.345 |
15 | 189477 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 370358 | 10 |
0.370 | 362519 | 7 |
0.375 | 429934 | 8 |
0.380 | 509329 | 16 |
0.385 | 281605 | 6 |
Last trade - 13.37pm 31/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online